Standard operating procedure

Similar documents
Recommendation for the basic surveillance of Eudravigilance Veterinary data

VICH GL30 on pharmacovigilance of veterinary medicinal products: controlled list of terms

Standard operating procedure

PRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 12 to 14 October 2004

Reflection paper on promotion of pharmacovigilance reporting

Committee for Medicinal Products for Veterinary Use (CVMP) Work Plan 2018

Draft ESVAC Vision and Strategy

Monthly report on application procedures, guidelines and related documents for veterinary medicines

Standard operating procedure

Legislation, Registration and Control Procedures for Veterinary Medicinal Products in the European Union

Opinion of the Committee for Medicinal Products for Veterinary Use pursuant to Article 30(3) of Regulation (EC) No 726/2004

Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of December 2016

Committee for Medicinal Products for Veterinary Use (CVMP) Meeting of July 2016

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

PRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 13 to 15 July 2004

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE. Monthly Report of Application Procedures, Guidelines and Related Documents

European Medicines Agency role and experience on antimicrobial resistance

Guideline on quality data requirements for veterinary medicinal products intended for minor use or minor species (MUMS)/limited market

Giles Davis., BVSc., GPCertSAP,, MRCVS

Committee for Medicinal Products for Veterinary Use

PRESS RELEASE COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Veterinary pharmacovigilance 2014

Review of Legislation for Veterinary Medicinal Products Version 2

Units of measurement for animals for the collection of data per animal species: Defined Daily Dose (DDDvet) and Defined Course Dose (DCDvet)

ESVAC (European Surveillance of Veterinary Antimicrobial Consumption)

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REVISED GUIDELINE ON THE SPC FOR ANTIMICROBIAL PRODUCTS

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)

MedDRA Important Medical Events (IME) in the EU. Patricia Mozzicato, MD MedDRA MSSO

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

European Public MRL assessment report (EPMAR)

CVMP strategy on antimicrobials

Specificities of Products for Veterinary Use

Committee for Medicinal Products for Veterinary Use

Committee for Medicinal Products for Veterinary Use

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

PRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

Scientific Discussion post-authorisation update for Rheumocam extension X/007

CVMP Monthly report of application procedures, guidelines and related documents

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE. Monthly Report of Application Procedures, Guidelines and Related Documents

Questions and answers on serious non-fatal adverse events and reporting rules

Update on European Agencies activities in the field of AMR

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

Guideline on the conduct of efficacy studies for intramammary products for use in cattle

EU strategy to fight against Antimicrobial Resistance

Public bulletin - Veterinary pharmacovigilance 2010

3rd International Symposium on Veterinary Pharmacovigilance Berlin, 13-14th December 2010

Dr A T Sigobodhla. Regional Workshop for OIE National Focal Points for Veterinary Products (Cycle V): Ezulwini, Swaziland, 6-8 December 2017

HMA-V Action plan on antimicrobial issues Version for publication (27 January 2011)

Antimicrobial resistance (AMR): Presentation on the joint EMA/EFSA RONAFA opinion Harmonisation of SPCs of antimicrobial veterinary medicines

Guideline on the summary of product characteristics (SPC) for veterinary medicinal products containing antimicrobial substances Draft

Dr. Gérard Moulin AFSSA/ANMV OIE Collaborating Centre on Veterinary medicinal products BP FOUGERES CEDEX, FRANCE

OIE Conference on Veterinary Medicinal Products in the Middle East

Veterinary pharmacovigilance 2016

COMMISSION OF THE EUROPEAN COMMUNITIES

MAXIMUM RESIDUE LIMITS FOR VETERINARY MEDICINAL PRODUCTS

CVMP activities regarding antimicrobials Ongoing and recent activities

Maximum Residue Limits (MRLs) and Consumer safety. Presented by: Isaura Duarte, European Medicines Agency

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC)

Request for advice on the impact on public health and animal health of the use of antibiotics in animals

Veterinary antimicrobials: state of play and future developments 2013 European Medicines Agency/IFAH- Europe Info Day 7-8 March 2013

PRESS RELEASE COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE Meeting of 7-9 November 2006

All medicinal products (for human and veterinary use) are regulated under the single Pharmaceutical Act.

STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: REPRODUCTION TESTING

Analogous application of the GDP Guidelines 2013/C 343/01 for veterinary medicinal products

COMMISSION DELEGATED REGULATION (EU) /... of XXX

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE. Monthly Report of Application Procedures, Guidelines and Related Documents

European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) Web Based Sales Data and Animal Population Data Collection Protocol (version 2)

Legislation on Veterinary Medicinal Products (VMPs) and legal status of relevant VMPs for anesthesia of finfish

Workshop on Strengthening livestock health and Veterinary Services. Kiev, 2-3 November 2010 TAIEX, AGR 42266

Council of the European Union Brussels, 13 June 2016 (OR. en)

Policy on Community-based Animal Health Workers

ESVAC meeting 3 March, 2017 EMA. Presented by Helen Jukes Co-chair RONAFA group, chair of the CVMP s Antimicrobials Working Party

Frequent Questions and Answers

V E T E R I N A R Y C O U N C I L O F I R E L A N D ETHICAL VETERINARY PRACTICE

Consumo y venta de antibióticos para uso en animales en Europa

RECENT ACTIVITIES OF THE NATIONAL FOCAL POINT FOR VETERINARY PRODUCTS - SWAZILAND PRESENTATION TO

Proposal for a Regulation on veterinary medicinal products

VICH Topic GL20 EFFICACY OF ANTHELMINTICS: SPECIFIC RECOMMENDATIONS FOR FELINE

COMMISSION DELEGATED REGULATION (EU)

Project Protocol Number UNIVERSITY OF HAWAII INSTITUTIONAL ANIMAL CARE &USE COMMITTEE 2002 VERTEBRATE ANIMAL USE PROTOCOL FORM

EMA advice on the impact of the use of antibiotics on public and animal health: Potential impact on the authorisation of antimicrobials

European public MRL assessment report (EPMAR)

Dr. Gérard Moulin Anses/ANMV OIE Collaborating Centre on Veterinary medicinal products BP FOUGERES CEDEX, FRANCE

Veterinary pharmacovigilance Public bulletin

Antimicrobial Resistance Direction Statement for Animals and Plants, and Work Programme

Introduction SEAVDRAC. 23 October Prof G E Swan. Southern and Eastern African Veterinary Drug Regulatory Affairs conference

Dr Dooshima Kwange Department of Veterinary and Pest Control Services FMARD

Focus group on promotion of PhV for food producing animals MAH view. IFAH-Europe Tony Simon 23rd November 2016

Medicines for bees. Establishment of maximum residue limits. Principles for marketing authorisations

Antimicrobial Resistance, yes we care! The European Joint Action

Results of the questionnaire on Veterinary Medicinal Products in the Middle East Damascus, Syria, 2-4 December 2009

EFSA-EMA Joint Scientific Opinion

PRESS RELEASE COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Snapshot Current Vet Drugs AMR Initiatives

Metacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs, cats and guinea pigs.

VICH Topic GL19 EFFICACY OF ANTHELMINTICS: SPECIFIC RECOMMENDATIONS FOR CANINES

Approved by Research Committee in November 2016.

Committee for Medicinal Products for Veterinary Use

Transcription:

Standard operating procedure Title: Annual review of VeDDRA list to be used in EudraVigilance Veterinary Status: PUBLIC Document no.: SOP/V/4019 Lead author Approver Effective date: 15-MAY-15 Name: Raquel Gopal Name: Kornelia Grein Review date: 15-MAY-18 Signature: on file Signature: on file Supersedes: SOP/V/4019 (22-JUN-11) Date: 13-MAY-15 Date: 12-MAY-15 TrackWise record no.: 4062 1. Purpose This document describes the steps taken to invite comments from national competent authorities and interested parties and to subsequently update the Combined VeDDRA 1 list of clinical terms for reporting suspected adverse reactions in animals and humans to veterinary medicinal products (VMPs) used in the electronic reporting of adverse events to VMPs via EudraVigilance Veterinary (EVVet). The list shall be reviewed and updated annually. 2. Scope This standard operating procedure (SOP) applies to the CVMP Pharmacovigilance Working Party secretariat being part of the Veterinary Medicines department (PhVWP-V secretariat), CVMP, CVMP Pharmacovigilance Working Party (PhVWP-V) and the VeDDRA Sub-Group (Sub-Group). The target groups for the call for comments are the Member States national competent authorities and interested parties. 3. Responsibilities It is the responsibility of the Head of the Animal and Public Health service to ensure that this procedure is adhered to. 1 Veterinary Dictionary for Drug Regulatory Activities 30 Churchill Place Canary Wharf London E14 5EU United Kingdom Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact An agency of the European Union European Medicines Agency, 2015. Reproduction is authorised provided the source is acknowledged.

It is the responsibility of the pharmacovigilance scientific administrator () to initiate the call for comments, collect, collate and circulate the comments, arrange for required meetings and publish the outcome. The roles responsible for each step are further detailed under section 9. The overall estimated time frame for this procedure is half a year. 4. Changes since last revision Exclusion of the List of species and breeds for electronic reporting of adverse reactions in veterinary pharmacovigilance (EMA/CVMP/553/2003) and List of additional controlled terminology for electronic submission of reports on adverse reactions to veterinary medicinal products (EMA/CVMP/556/04) from the scope of the annual review; Proposals for amendments to these lists are taken forward via the Consultative Group on Veterinary Pharmacovigilance Systems (formerly known as the EudraVigilance Veterinary Joint Implementation Group); Changes reflecting the restructuring of the division and the rebranding of the Agency; Update of deadline for submission of comments on VeDDRA; Inclusion of agreed deadline for implementation of the revised list in EudraVigilance Veterinary; Update of location of electronic archive for documents in DREAM. 5. Documents needed for this SOP This SOP applies to the Combined VeDDRA list of clinical terms for reporting suspected adverse reactions in animals and humans to veterinary medicinal products (EMA/CVMP/10418/2009) for use in EudraVigilance Veterinary. The SOP applies to the following documents related to the VeDDRA review: Permanent call for comments on VeDDRA for EudraVigilance Veterinary (EMA/123352/2004); Non-current VeDDRA low level terms (LLT) and codes (EMA/360871/2010). 6. Related documents ATCvet: The Anatomical Therapeutic Chemical classification system for veterinary medicinal products, for the classification of substances intended for therapeutic use; developed and maintained by the WHO Collaborating Centre for Drug Statistics Methodology (www.whocc.no); The Standard Terms on Pharmaceutical Dosage Forms, Routes of Administration and Containers, as published by the Council of Europe, is used for the description of the pharmaceutical dosage forms. SOP/V/4019 15-MAY-15 Page 2/6

7. Definitions Call for comments CVMP EVVet PhVWP-V VeDDRA VeDDRA Sub-Group A document inviting submission of comments on the VeDDRA list used for EVVet Committee for Medicinal Products for Veterinary Use EudraVigilance Veterinary - The European data processing network and database management system for pharmacovigilance of veterinary medicinal products in the European Economic Area (EEA) CVMP Pharmacovigilance Working Party Scientific administrator in veterinary pharmacovigilance Veterinary Dictionary for Drug Regulatory Affairs Working group consisting of nominated experts from the CVMP Pharmacovigilance Working Party, representatives from the pharmaceutical industry and VICH partners SOP/V/4019 15-MAY-15 Page 3/6

8. Process map(s)/flow chart(s) SOP/V/4019 15-MAY-15 Page 4/6

9. Procedure Step Action Responsibility 1.0 Check whether call for comments needs revision. If yes, go to step 1.1 If no, go to step 2.0 1.1 Revise Call for comments. 1.2 Publish revised Call for comments in the pharmacovigilance area (EVVet subheading) for veterinary medicines on the EMA public website. Proceed to 2.0 2.0 Collect and collate comments received by annual deadline, 1 March (of each year), as specified in call for comments, and circulate to the VeDDRA sub-group, copying the PhVWP-V. 3.0 VeDDRA Sub-Group reviews and proposes revisions to the VeDDRA list at VeDDRA sub-group meeting. Prepare list of changes and update non-current VeDDRA LLTs and codes list, if applicable. 3.1 VeDDRA Sub-Group considers adoption of updated list (during meeting or by written procedure, as appropriate). Did the VeDDRA Sub-Group adopt a (revised) list? If yes, go to 3.2 If no, go to 3.0 3.2 PhVWP-V considers adoption of proposals from VeDDRA sub-group. Did PhVWP-V adopt the proposals? If yes, go to 3.3 If no, go to 3.0 3.3 CVMP considers adoption of proposals from PhVWP-V. Did CVMP adopt the proposals? If yes, go to 4.0 If no, go to 3.0 4.0 Publish updated lists (including excel-versions, list of changes and non-current VeDDRA LLTs and codes, if applicable) in the pharmacovigilance area (EVVet subheading) for veterinary medicines on the EMA public website. 5.0 Forward updated lists (including list of changes) to ICT for implementation in EVVet by 1 October. SOP/V/4019 15-MAY-15 Page 5/6

10. Records The adopted lists (including excel-versions and list of changes, if applicable) are available on the EMA public website under http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_ 000173.jsp&murl=menus/regulations/regulations.jsp&mid=WC0b01ac058002dea6&jsenabled=true. The electronic archive of the comments received and versions of the lists, as well as related correspondence, shall be maintained in the relevant folders in DREAM: Cabinets/03. Pharmacovigilance/PhV - Veterinary/Pharmacovigilance guidance/veddra & other standard lists. SOP/V/4019 15-MAY-15 Page 6/6